Cyclotriazadisulfonamide
Cyclotriazadisulfonamide (CADA) is a specific CD4-targeted HIV entry inhibitors. Cyclotriazadisulfonamide (CADA) inhibits the co-translational translocation of human CD4 (huCD4) into the ER lumen in a signal peptide (SP) -dependent way. Cyclotriazadisulfonamide is also a Sec61 translocon inhibitor[1][2][3].
Product Specifications
CAS Number
182316-44-5
Product Name Alternative
CADA
UNSPSC
12352005
Target
HIV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/cyclotriazadisulfonamide.html
Purity
98.45
Solubility
DMSO : 33.33 mg/mL (ultrasonic; warming)
Smiles
O=S(N1CC(CN(S(=O)(C2=CC=C(C)C=C2)=O)CCCN(CC3=CC=CC=C3)CCC1)=C)(C4=CC=C(C)C=C4)=O
Molecular Formula
C31H39N3O4S2
Molecular Weight
581.79
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
HIV-1
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Fibronectin (TV-1), CF488A conjugate, 0.1mg/mL
Fibronectin (Fn-3), CF405S conjugate, 0.1mg/mL
MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (VU-11D1), CF647 conjugate, 0.1mg/mL
Human IgG Immunoglobulin (IG266), CF594 conjugate, 0.1mg/mL
